- Phase 1 clinical evaluation of HIV vaccine candidates, in HIV uninfected individuals
- Phase 1 clinical evaluation of HIV vaccine candidates, in people living with HIV and undergoing antiretroviral treatment interruption
- Exploring self-amplifying RNA platforms to optimize the immune responses elicited by our vaccines